circPPP2R4 promotes colorectal cancer progression and reduces ROS production through the miR‐646/FOXK1 axis

Author:

Hong Yuntian123ORCID,Chen Baoxiang123,Wang Chun4,Gui Rui5,Zhai Xiang123,Qian Qun123,Ren Xianghai123,Xie Xiaoyu123,Jiang Congqing123ORCID

Affiliation:

1. Department of Colorectal and Anal Surgery Zhongnan Hospital of Wuhan University Wuhan China

2. Clinical Center of Intestinal and Colorectal Diseases of Hubei Province Wuhan China

3. Key Laboratory of Intestinal and Colorectal Diseases of Hubei Province Wuhan China

4. Department of Gastroenterology Zhongnan Hospital of Wuhan University Wuhan China

5. Department of Infectious Diseases Southwest Hospital, Third Military Medical University (Army Medical University) Chongqing China

Abstract

AbstractCircular RNAs (circRNAs) play important roles in colorectal cancer (CRC) development and progression. This study aimed to investigate the function and molecular mechanism of circPPP2R4 in CRC. Based on bioinformatic analyses and validation by qRT‐PCR, we identified a novel circRNA, circPPP2R4, which was upregulated in CRC tissues. Receiver operating characteristic curve analysis implied a high diagnostic value of circPPP2R4 for CRC. Additionally, high circPPP2R4 levels were positively correlated with advanced clinical stage and lymph node metastasis. Functionally, circPPP2R4 overexpression facilitated CRC cells proliferation, migration and invasion, whereas circPPP2R4 knockdown attenuated the malignant behaviors. In mouse models, circPPP2R4 overexpression remarkably promoted tumor growth and lung metastasis. Mechanistically, a series of experiments containing RIP, RNA pull‐down, and dual‐luciferase reporter assays revealed the circPPP2R4/miR‐646/FOXK1 axis in CRC. Further experiments were conducted to verify that circPPP2R4 reduced reactive oxygen species generation to exert its oncogenic function by sponging miR‐646 to upregulate FOXK1 expression. For the first time, we identified the regulatory role of circPPP2R4 in CRC pathogenesis, providing a potential diagnostic biomarker and therapeutic strategy for CRC.

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3